Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Anesthesiology. 2019 Jun;130(6):958–970. doi: 10.1097/ALN.0000000000002668

Table 5.

Summary of 1-year change scores in quality of life and neurological outcomes measures.

Variable Lidocaine (mean ± SD) Placebo (mean ± SD) P-Value*
Quality of Life CESD (−) −1.27 ± 7.7 −0.89 ± 7.9 >0.999
DASI (+) 6.3 ± 18.3 6.96 ± 16.9 >0.999
STAI (−) −6.7 ± 12.7 −6.39 ± 10.3 >0.999
Symptoms Limitation (−) −1.39 ± 3.8 −1.48 ± 3.8 >0.999
OARS-IADL (−) −0.15 ± 2.1 −0.31 ± 2.6 >0.999
Cognitive Difficulties (−) −0.46 ± 16.1 −1.02 ± 17 >0.999
Social Activities (−) −0.2 ± 3.2 0.03 ± 3.4 >0.999
Social Support (+) 0.71 ± 13.4 −1.16 ± 12.9 0.696
Work Activities (−) −1.37 ± 4.3 −1.42 ± 4.1 >0.999
General Health Perception (−) −0.28 ± 1.2 −0.43 ± 1.1 >0.999

Neurologic Outcomes NIHSS (−) 0.05 ± 0.7 0.07 ± 0.6 >0.999
WPNS (+) 0.02 ± 1.1 −0.02 ± 1.2 >0.999

A minus sign (−) indicates that a lower score is better; a plus sign (+) indicates that a higher score is better. CESD: Center for Epidemiologic Studies – Depression Scale, DASI: Duke Activity Status Index, STAI: State Trait Anxiety Inventory, OARS-IADL: Duke Older American Resources Services Procedures – Instrumental Activities of Daily Living, NIHSS: National Institutes of Health Stroke Scale, WPNS: Western Perioperative Neurologic Scale.

*

Adjusted for multiple comparisons.